FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Workshop on Patient-focused Drug Development

[ Price : $8.95]

Federal Register notice: FDA announces a 3/19/18 public workshop entitled Patient-Focused Drug Development: Developing and Submitt...

Appeals Court Rules Against Amgen in Neupogen Biosimilar Case

[ Price : $8.95]

The Federal Circuit Court of Appeals rules against Amgen in the continuing dispute between it and Sandoz over application of provi...

FDA Still Against Using Morcellators for Most Fibroids

[ Price : $8.95]

An updated FDA assessment says the agency continues to caution against using laparoscopic power morcellators to treat presumed ute...

2014 Baxter FDA-483 Released

[ Price : $8.95]

FDA releases the FDA-483 issued after a 2014 inspection at Baxter Healthcare.

Chemence Medicals Exofin Fusion Skin Closure Device Cleared

[ Price : $8.95]

FDA clears a Chemence Medical 510(k) to market and sell Exofin Fusion, a new skin closure system for medium to large wounds.

FDA Wants More Consumer Information Available

[ Price : $8.95]

HHS lists drug and medical device regulatory priorities for FDA.

FDA Clears Gel-e Adhesive Bandage

[ Price : $8.95]

FDA clears a Gel-e Inc. 510(k) for its adhesive bandage for prescription and over-the-counter use in managing moderately to heavil...

FDA Accepts sBLA for Odivo/Yeroy Combination

[ Price : $8.95]

FDA accepts a Bristol-Myers Squibb supplemental BLA for priority review of Opdivo (nivolumab) plus Yervoy (ipilimumab) to treat in...

Gottlieb Sets 2018 FDA Goals

[ Price : $8.95]

FDA commissioner Scott Gottlieb lays out regulatory priorities for 2018 for drugs and medical devices.

FDA Gives Docs Antibiotics Management Tool

[ Price : $8.95]

FDA opens a Web site to give doctors antibiotic breakpoint information in a more efficient and timely way.